Valine is one of the three branched-chain amino acids (BCAAs) and is unique among them in that it is exclusively glucogenic — it is converted to glucose through the pathways of gluconeogenesis but cannot be converted to ketone bodies. This exclusive glucogenic classification makes valine uniquely important for the maintenance of blood sugar during exercise and during fasting, when glucose is in short supply and must be synthesised from non-carbohydrate precursors. During sustained exercise (particularly endurance exercise lasting more than 60-90 minutes), muscle glycogen stores are depleted and the liver must increase its rate of gluconeogenesis to maintain blood sugar levels. Valine is released from muscle protein breakdown during exercise and is taken up by the liver, where it is converted to glucose through the gluconeogenic pathway. This valine-induced gluconeogenesis is one of the primary mechanisms by which the body maintains blood sugar during prolonged exercise, and it is one of the most important metabolic contributions of valine to athletic performance and to metabolic health.
Valine and the Alanine Cycle
Valine is also a critical component of the alanine cycle — the metabolic pathway by which nitrogen from the breakdown of amino acids in muscle is transported to the liver for conversion to urea and excretion. In the alanine cycle, the nitrogen from the deamination of amino acids in muscle is transferred to pyruvate (which is derived from glycolysis) to form alanine. The alanine is released into the blood and taken up by the liver, where it is converted back to pyruvate (for gluconeogenesis) and to urea (for nitrogen excretion). This alanine cycle is one of the primary mechanisms by which muscle disposes of the nitrogen that is generated by the deamination of amino acids during exercise and by which the liver generates glucose from the carbon skeletons of amino acids during exercise and fasting. Valine contributes to this cycle both as a source of nitrogen (through its deamination in muscle) and as a source of the glucose carbon skeleton (through its conversion to pyruvate in the liver following its uptake from the blood).
The importance of valine for the alanine cycle and for gluconeogenesis is underscored by the observation that the plasma levels of valine and the other BCAAs fall during prolonged endurance exercise, reflecting their uptake by the liver and their metabolism in the gluconeogenic pathway. The fall in plasma valine during exercise is proportional to the intensity and duration of the exercise, and it is one of the metabolic markers of the transition from the fed state to the fasted state during exercise. Athletes who supplement with valine (as part of a BCAA preparation) during prolonged endurance exercise may be able to partially offset the fall in plasma valine levels and to maintain a higher rate of gluconeogenesis, which may improve performance during long events and may reduce the risk of hypoglycaemia in the later stages of prolonged exercise.
Valine and the Central Fatigue Hypothesis
One of the most important and least appreciated functions of valine is its competition with tryptophan for transport into the brain. Tryptophan is transported into the brain by the large neutral amino acid transporter (LAT1), which also transports valine, isoleucine, leucine, tyrosine, and phenylalanine. During exercise, when plasma tryptophan levels rise relative to the BCAAs (as the ratio of free fatty acids to albumin increases in the blood, displacing tryptophan from its albumin binding sites and increasing the free tryptophan concentration), more tryptophan enters the brain, serotonin synthesis increases, and central fatigue develops. The central fatigue hypothesis proposes that the increase in brain serotonin during prolonged exercise is one of the primary mechanisms of central fatigue — the fatigue that originates in the brain rather than in the muscle. Valine supplementation during exercise may combat central fatigue by competing with tryptophan for the LAT1 transporter, reducing the amount of tryptophan that enters the brain and thereby limiting the increase in brain serotonin that underlies central fatigue.
Practical Application
For general valine supplementation (as an athletic performance and anti-fatigue strategy), the evidence-based approach is to supplement with all three BCAAs rather than with valine alone — the metabolic effects of the BCAAs are interconnected and are most effective when all three are present. The standard BCAA supplement contains leucine, isoleucine, and valine in approximately 2:1:1 or 3:1:1 ratios, and the evidence-based dose for total BCAAs is 5-10g daily, taken before, during, or after exercise to support muscle protein synthesis, to reduce exercise-induced muscle damage, and to combat central fatigue. The specific use of valine for central fatigue prevention is best addressed by taking BCAAs during exercise (at a dose of 5-8g per hour of exercise, divided into smaller doses taken every 15-20 minutes). For comprehensive athletic performance support, valine pairs well with the other BCAAs (particularly leucine for mTOR activation and isoleucine for the complete BCAA complex), with carbohydrate (which provides the glucose that is the primary fuel for high-intensity exercise and which reduces the dependence on gluconeogenesis from amino acids), with caffeine (which combats central fatigue through adenosine receptor antagonism and which synergises with BCAA supplementation for the reduction of central fatigue during exercise), and with the omega-3 fatty acids (which have anti-inflammatory effects that reduce the exercise-induced muscle damage and the inflammatory mediators that contribute to fatigue).
Leave a Reply